TKUN Stock Overview
Tikun Olam-Cannbit Pharmaceuticals Ltd engages in the cultivation, production, marketing, storage, distribution, export and import, and sale of cannabis-based products in Israel.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Tikun Olam-Cannbit Pharmaceuticals Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₪0.30 |
52 Week High | ₪0.57 |
52 Week Low | ₪0.23 |
Beta | 1.14 |
1 Month Change | 18.97% |
3 Month Change | -10.42% |
1 Year Change | -37.03% |
3 Year Change | -95.31% |
5 Year Change | -98.57% |
Change since IPO | -99.98% |
Recent News & Updates
Recent updates
Risks To Shareholder Returns Are Elevated At These Prices For Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN)
Jul 21Would Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Be Better Off With Less Debt?
Oct 03Is Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Weighed On By Its Debt Load?
Jun 03Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Is Carrying A Fair Bit Of Debt
Oct 17Is Tikun Olam - Cannbit Pharmaceuticals (TLV:TKUN) Using Debt Sensibly?
May 19Shareholders Of Tikun Olam - Cannbit Pharmaceuticals (TLV:TKUN) Must Be Happy With Their 135% Total Return
Mar 19How Much Did Tikun Olam - Cannbit Pharmaceuticals'(TLV:TKUN) Shareholders Earn From Share Price Movements Over The Last Five Years?
Dec 02Shareholder Returns
TKUN | IL Pharmaceuticals | IL Market | |
---|---|---|---|
7D | 18.0% | -6.0% | -3.5% |
1Y | -37.0% | -17.7% | 8.3% |
Return vs Industry: TKUN underperformed the IL Pharmaceuticals industry which returned -17.7% over the past year.
Return vs Market: TKUN underperformed the IL Market which returned 8.3% over the past year.
Price Volatility
TKUN volatility | |
---|---|
TKUN Average Weekly Movement | 11.2% |
Pharmaceuticals Industry Average Movement | 6.1% |
Market Average Movement | 4.4% |
10% most volatile stocks in IL Market | 7.9% |
10% least volatile stocks in IL Market | 3.1% |
Stable Share Price: TKUN's share price has been volatile over the past 3 months.
Volatility Over Time: TKUN's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of IL stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 102 | Yifat Karib | www.tikun-olam.org.il |
Tikun Olam-Cannbit Pharmaceuticals Ltd engages in the cultivation, production, marketing, storage, distribution, export and import, and sale of cannabis-based products in Israel. The company provides medical cannabis products for the treatment and relief of symptoms in a wide variety of medical indications. It also offers training and patient care services.
Tikun Olam-Cannbit Pharmaceuticals Ltd Fundamentals Summary
TKUN fundamental statistics | |
---|---|
Market cap | ₪24.36m |
Earnings (TTM) | -₪88.89m |
Revenue (TTM) | ₪44.23m |
0.6x
P/S Ratio-0.3x
P/E RatioIs TKUN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
TKUN income statement (TTM) | |
---|---|
Revenue | ₪44.23m |
Cost of Revenue | ₪32.70m |
Gross Profit | ₪11.53m |
Other Expenses | ₪100.41m |
Earnings | -₪88.89m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -1.10 |
Gross Margin | 26.06% |
Net Profit Margin | -200.97% |
Debt/Equity Ratio | 42.3% |
How did TKUN perform over the long term?
See historical performance and comparison